Melphalan flufenamide (melflufen) is a first-in-class peptide–drug conjugate (PDC) that targets aminopeptidases and rapidly releases alkylating agents into tumor cells [28,29,30,31,32]. This evidence concerns the gene CPQ and neoplasm.